Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11807651 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2023-11-07 |
| 11760709 | Method for preparing resorcinol through micro-channel reaction | Yantao Hao, Guodong Liang, Qinqin Gao, Pengshuai Li, Ting Zhang | 2023-09-19 |
| 11098064 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2021-08-24 |
| 10835533 | 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor | Shelley Allen, Steven W. Andrews, Brian Baer, Zackary Crane, Daniel J. Watson | 2020-11-17 |
| 10745419 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2020-08-18 |
| 10729678 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2020-08-04 |
| 10398683 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2019-09-03 |
| 10329288 | Process for preparing a compound | Chong Han, Keena Lynn Green, Francis Gosselin, Michelangelo Scalone, Paul Nichols +4 more | 2019-06-25 |
| 9980944 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2018-05-29 |
| 9598376 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2017-03-21 |
| 9562016 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2017-02-07 |
| 9382212 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2016-07-05 |
| 9238627 | Preparation of and formulation comprising a MEK inhibitor | Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more | 2016-01-19 |
| 8648087 | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | Joseph P. Lyssikatos, Julie Marie Greschuk, Fredrik P. Marmsater, Qian Zhao, D. David Hennings | 2014-02-11 |
| 8299021 | Macrocyclic inhibitors of hepatitis C virus replication | Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more | 2012-10-30 |
| 7829665 | Macrocyclic inhibitors of hepatitis C virus replication | Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more | 2010-11-09 |